Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
3(43%)
Results Posted
67%(2 trials)

Phase Distribution

Ph not_applicable
2
29%
Ph phase_2
4
57%

Phase Distribution

0

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
4(66.7%)
N/ANon-phased studies
2(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

7

all time

Status Distribution
Active(4)
Completed(3)

Detailed Status

Completed3
Active, not recruiting2
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
3
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 24 (66.7%)
N/A2 (33.3%)

Trials by Status

recruiting114%
not_yet_recruiting114%
active_not_recruiting229%
completed343%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
PROCEDURE
Total Trials
7